IBM AI finds new peptides – paving the way to better drug design

Antibiotic resistance is no joke. We need new antibiotics, and we need them fast. In the US alone, nearly three million people¹ get infected with antibiotic-resistant bacteria or fungi every year¹. But very few new antibiotics are being developed to replace those that no longer work. That's because drug design is an extremely difficult and lengthy process -- there are more possible chemical combinations of a new molecule than there are atoms in the Universe.